Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119608784> ?p ?o ?g. }
- W2119608784 abstract "Susac’s Syndrome (SS) consists of the triad of encephalopathy, branch retinal artery occlusions (BRAO) and hearing loss (HL). Histopathologically, SS is characterised by a microangiopathy, and some observations suggest that an immune-mediated damage of endothelial cells might play a role. These findings also implicate a similarity between SS and other autoimmune diseases, most notably juvenile dermatomyositis (JDM). However, SS and JDM are commonly thought to affect distinct and non-overlapping sets of organs, and it is currently not clear how these specificities arise. Moreover, in the absence of clinical trials, some authors suggest that therapeutic approaches in SS should rely on the model of other autoimmune diseases such as JDM. Here, we report a case of SS in a 32-year-old pregnant woman. She initially was admitted to the hospital with subacute severe encephalopathy and multifocal neurologic signs. As cranial magnetic resonance imaging (MRI) revealed multifocal white matter lesions including the corpus callosum, erroneously a diagnosis of multiple sclerosis (MS) was made, and intravenous methylprednisolone (IVMP) therapy was initiated. A few days later, an exanthema appeared on the trunk and extremities, which was diagnosed as livedo racemosa (LR). Several weeks later, the patient was readmitted to the clinic with an obscuration of her left visual hemifield and a bilateral HL. Ophthalmologic examination revealed extensive ischemic damage to both retinae. Now the correct diagnosis of SS was established, based on the above triad of clinical symptoms in conjunction with typical MRI and fundoscopic findings. When SS was diagnosed, the standard therapy with intravenous cyclophosphamide (IVCTX) was not instituted because of a significant risk of permanent infertility. Instead, sustained control of disease activity could be achieved with a therapeutic regime combining prednisolone, intravenous immunoglobulins (IVIG), mycophenylate mofetil (MM), and methotrexate (MTX). An association with LR has only been described in very few cases of SS before and further underlines the pathogenetic relationship between SS and other autoimmune diseases such as JDM. In young women with SS and the desire for a child the combination of MM and MTX may represent a reasonable alternative to IVCTX." @default.
- W2119608784 created "2016-06-24" @default.
- W2119608784 creator A5014832282 @default.
- W2119608784 creator A5028578670 @default.
- W2119608784 creator A5034571694 @default.
- W2119608784 creator A5045369940 @default.
- W2119608784 creator A5050429661 @default.
- W2119608784 creator A5075094490 @default.
- W2119608784 creator A5077353957 @default.
- W2119608784 creator A5090960047 @default.
- W2119608784 date "2013-11-25" @default.
- W2119608784 modified "2023-10-07" @default.
- W2119608784 title "Encephalopathic Susac’s Syndrome associated with livedo racemosa in a young woman before the completion of family planning" @default.
- W2119608784 cites W1985208726 @default.
- W2119608784 cites W1985512083 @default.
- W2119608784 cites W1995482191 @default.
- W2119608784 cites W2002083801 @default.
- W2119608784 cites W2011950589 @default.
- W2119608784 cites W2016488893 @default.
- W2119608784 cites W2030296971 @default.
- W2119608784 cites W2045810174 @default.
- W2119608784 cites W2047049772 @default.
- W2119608784 cites W2049831025 @default.
- W2119608784 cites W2067857936 @default.
- W2119608784 cites W2099029081 @default.
- W2119608784 cites W2101539806 @default.
- W2119608784 cites W2122510357 @default.
- W2119608784 cites W2152779574 @default.
- W2119608784 cites W4244240329 @default.
- W2119608784 doi "https://doi.org/10.1186/1471-2377-13-185" @default.
- W2119608784 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4222806" @default.
- W2119608784 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24274741" @default.
- W2119608784 hasPublicationYear "2013" @default.
- W2119608784 type Work @default.
- W2119608784 sameAs 2119608784 @default.
- W2119608784 citedByCount "14" @default.
- W2119608784 countsByYear W21196087842016 @default.
- W2119608784 countsByYear W21196087842018 @default.
- W2119608784 countsByYear W21196087842019 @default.
- W2119608784 countsByYear W21196087842020 @default.
- W2119608784 countsByYear W21196087842021 @default.
- W2119608784 countsByYear W21196087842022 @default.
- W2119608784 crossrefType "journal-article" @default.
- W2119608784 hasAuthorship W2119608784A5014832282 @default.
- W2119608784 hasAuthorship W2119608784A5028578670 @default.
- W2119608784 hasAuthorship W2119608784A5034571694 @default.
- W2119608784 hasAuthorship W2119608784A5045369940 @default.
- W2119608784 hasAuthorship W2119608784A5050429661 @default.
- W2119608784 hasAuthorship W2119608784A5075094490 @default.
- W2119608784 hasAuthorship W2119608784A5077353957 @default.
- W2119608784 hasAuthorship W2119608784A5090960047 @default.
- W2119608784 hasBestOaLocation W21196087841 @default.
- W2119608784 hasConcept C126322002 @default.
- W2119608784 hasConcept C126838900 @default.
- W2119608784 hasConcept C134018914 @default.
- W2119608784 hasConcept C141071460 @default.
- W2119608784 hasConcept C142724271 @default.
- W2119608784 hasConcept C143409427 @default.
- W2119608784 hasConcept C16005928 @default.
- W2119608784 hasConcept C203014093 @default.
- W2119608784 hasConcept C2776513394 @default.
- W2119608784 hasConcept C2776874634 @default.
- W2119608784 hasConcept C2778183499 @default.
- W2119608784 hasConcept C2778552304 @default.
- W2119608784 hasConcept C2778621155 @default.
- W2119608784 hasConcept C2778751314 @default.
- W2119608784 hasConcept C2779134260 @default.
- W2119608784 hasConcept C2779328510 @default.
- W2119608784 hasConcept C2779974317 @default.
- W2119608784 hasConcept C2780640218 @default.
- W2119608784 hasConcept C2780868729 @default.
- W2119608784 hasConcept C555293320 @default.
- W2119608784 hasConcept C71924100 @default.
- W2119608784 hasConceptScore W2119608784C126322002 @default.
- W2119608784 hasConceptScore W2119608784C126838900 @default.
- W2119608784 hasConceptScore W2119608784C134018914 @default.
- W2119608784 hasConceptScore W2119608784C141071460 @default.
- W2119608784 hasConceptScore W2119608784C142724271 @default.
- W2119608784 hasConceptScore W2119608784C143409427 @default.
- W2119608784 hasConceptScore W2119608784C16005928 @default.
- W2119608784 hasConceptScore W2119608784C203014093 @default.
- W2119608784 hasConceptScore W2119608784C2776513394 @default.
- W2119608784 hasConceptScore W2119608784C2776874634 @default.
- W2119608784 hasConceptScore W2119608784C2778183499 @default.
- W2119608784 hasConceptScore W2119608784C2778552304 @default.
- W2119608784 hasConceptScore W2119608784C2778621155 @default.
- W2119608784 hasConceptScore W2119608784C2778751314 @default.
- W2119608784 hasConceptScore W2119608784C2779134260 @default.
- W2119608784 hasConceptScore W2119608784C2779328510 @default.
- W2119608784 hasConceptScore W2119608784C2779974317 @default.
- W2119608784 hasConceptScore W2119608784C2780640218 @default.
- W2119608784 hasConceptScore W2119608784C2780868729 @default.
- W2119608784 hasConceptScore W2119608784C555293320 @default.
- W2119608784 hasConceptScore W2119608784C71924100 @default.
- W2119608784 hasIssue "1" @default.
- W2119608784 hasLocation W21196087841 @default.
- W2119608784 hasLocation W21196087842 @default.
- W2119608784 hasLocation W21196087843 @default.
- W2119608784 hasLocation W21196087844 @default.
- W2119608784 hasOpenAccess W2119608784 @default.